Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00271908
Status:
COMPLETED
Last Update Posted:
2017-02-28
First Post:
2005-12-30
Brief Title:
C2P With Venues Connect to Protect Partnerships For Youth Prevention Interventions
Sponsor:
University of North Carolina Chapel Hill
Organization:
University of North Carolina Chapel Hill
Study Overview
Official Title:
Connect to Protect Partnerships for Youth Prevention Interventions Phase III Full Evaluation
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
During Phase III Adolescent Trials Network for HIVAIDS Interventions ATNConnect-to-Protect C2P site staff their official community partners established in Phase I and newly invited community sector representatives ie individuals from various key parts of the community such as family spiritual or faith-based institutions business and government will form a coalition that will work toward achieving C2P objectives ATN 040b is the evaluation protocol for ATN 040 Phase III of C2P
Detailed Description:
Phase IIIs objective is to initiate and complete a community mobilization intervention aimed at reducing HIV incidence and prevalence among youth The intervention will consist of guiding C2P coalitions through a strategic planning process that will result in the development and implementation of a local action plan The action plan will focus on changing structural elements of the affected communities that are believed to be associated with youth HIV acquisition and transmission The effectiveness of the intervention will be evaluated by tracking venues where the population of interest congregates and trends in risk factors associated with HIV acquisition and transmission
ATN 040b evaluates annual anonymous data collection of two cohorts per participating ATNC2P site Both cohorts will represent a sites population of focus but will be recruited in different ways and for different activities
Cohort 1 will be referred to the site via Official Community Partners and word of mouth Each year of the study 10 to 20 individuals will be recruited to complete venue-tracking surveys as described in Section 21 N 40-80 per site over four years The results will either confirm that the population of focus can still be reached at previously identified congregation venues or reveal new ones that should be considered for further research activities Each year based on data from Cohort 1 ATNC2P site staff will go to two to three of the confirmed andor new congregation venues to recruit 20 to 30 participants per venue for Cohort 2 These participants will complete the HIV-related risk survey with the addition of the HIV-Ab assay in the final year only N 160-360 per site over four years Data will be used to evaluate the intervention within and across ATNC2P sites
ATN 040b evaluates annual anonymous data collection of two cohorts per participating ATNC2P site Both cohorts will represent a sites population of focus but will be recruited in different ways and for different activities
Cohort 1 will be referred to the site via Official Community Partners and word of mouth Each year of the study 10 to 20 individuals will be recruited to complete venue-tracking surveys as described in Section 21 N 40-80 per site over four years The results will either confirm that the population of focus can still be reached at previously identified congregation venues or reveal new ones that should be considered for further research activities Each year based on data from Cohort 1 ATNC2P site staff will go to two to three of the confirmed andor new congregation venues to recruit 20 to 30 participants per venue for Cohort 2 These participants will complete the HIV-related risk survey with the addition of the HIV-Ab assay in the final year only N 160-360 per site over four years Data will be used to evaluate the intervention within and across ATNC2P sites
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None